← FDA Drug Approvals (Drugs@FDA)
NORETHINDRONE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS · Approved 2013-09-13
Drug application
- FDA Application #
ANDA202014- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NORETHINDRONE
- Generic name
- NORETHINDRONE
- Active ingredients
- NORETHINDRONE
- Dosage form
- TABLET
- Route
- ORAL-28
- Marketing status
- Prescription
- Sponsor
- NOVAST LABS
- Manufacturer
- Northstar Rx LLC
- First approval
- 2013-09-13
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown